The pharmaceutical landscape is witnessing a development with the emergence of GLP-1 transdermal systems . These cutting-edge formulations offer a possible method to delivering glucagon-like peptide-1 medication for individuals managing the disease . Instead of injections , a convenient patch placed to the area could provide a steady dose of the me